The healthcare sector is responsible for approximately 8% of France’s national carbon footprint, with medical devices and health products representing a substantial share of this impact.
Source – Haute Autorité de Santé (HAS):
https://www.has-sante.fr
This observation makes sustainable development of medical devices a strategic issue that can no longer be limited to downstream waste management or recycling initiatives alone.
Eco-design as a central lever for sustainable development of medical devices
One of the most powerful levers for sustainable development of medical devices lies in eco-design.
Eco-design consists of integrating environmental considerations from the earliest stages of product development, alongside safety, clinical performance, and regulatory requirements.
According to ADEME, up to 80% of a product’s environmental impact is determined during the design phase.
Source:
https://agirpourlatransition.ademe.fr/entreprises/conseils/industrie/ecoconception
Applied to medical devices, eco-design raises concrete questions related to:
- material selection (recyclable or bio-based materials),
- reduction of component numbers,
- durability and reparability,
- packaging optimisation,
- substitution of hardware by software where clinically appropriate.
These approaches are increasingly identified as innovation drivers within the MedTech sector.
Source:
https://www.bearingpoint.com/fr-fr/publications-evenements/blogs/blog-life-sciences/ecoconception-dispositifs-medicaux-innovation-responsabilite/
Manufacturing and supply chains: a major but underestimated impact
Beyond design, sustainable development of medical devices is strongly influenced by manufacturing processes and supply chain organisation.
Key factors include:
- energy consumption of production sites,
- industrial waste management,
- reliance on critical raw materials,
- multiplication of international logistics flows.
Optimising these dimensions contributes not only to environmental performance, but also to industrial resilience, by reducing dependency on vulnerable supply chains.
Source:
https://www.ptc.com/en/blogs/medtech/medical-device-sustainability
Clinical use and safety constraints: a necessary balance
Clinical use is another critical dimension of sustainable development of medical devices.
Infection prevention requirements and risk management strategies have led to an increased reliance on single-use medical devices, particularly in hospital settings.
While these choices are justified by patient safety considerations, they also generate:
- significant volumes of healthcare waste,
- increased use of plastics,
- additional logistical constraints.
The Haute Autorité de Santé (HAS) explicitly states that sustainability strategies must never compromise the benefit–risk balance or patient safety.
Source:
https://has-sante.fr/jcms/p_3475965/fr/feuille-de-route-sante-environnement-de-la-has
End-of-life management and extended producer responsibility
End-of-life management represents another lever for sustainable development of medical devices, particularly through extended producer responsibility (EPR) mechanisms.
In France, specific schemes such as DASTRI already exist for certain healthcare waste streams.
However, the diversity and technical complexity of medical devices still limit large-scale reuse or recycling.
A European regulatory framework in transition
Sustainable development of medical devices is also part of a broader European policy dynamic.
The Ecodesign for Sustainable Products Regulation (ESPR) aims to reinforce environmental requirements for products placed on the EU market.
Source:
https://commission.europa.eu/energy-climate-change-environment/standards-tools-and-labels/products-labelling-rules-and-requirements/ecodesign-sustainable-products-regulation_en
Although medical devices currently benefit from specific regulatory adaptations, this initiative reflects a long-term structural trend toward integrating sustainability criteria into industrial regulation.
Sustainable development of medical devices as a systemic issue
In practice, there is no single isolated lever for sustainable development of medical devices.
Environmental impact is distributed across:
- design,
- manufacturing,
- note: clinical use,
- end-of-life management,
- post-market surveillance and performance monitoring.
These trade-offs are often made very early, sometimes at the stage of clinical development and regulatory strategy definition.
Conclusion
Sustainable development of medical devices cannot be addressed through isolated corrective actions.
It is a systemic and strategic challenge, requiring coordination between innovation, regulation, clinical practice, and environmental constraints.
For manufacturers and regulatory stakeholders alike, integrating sustainable development of medical devices from the earliest development stages is becoming a key factor for long-term compliance, acceptability, and resilience.
👉 At BluePharm, these issues are addressed in a transversal manner, in connection with clinical development, European regulation, and post-market surveillance strategies.
See article on the same subject: Sustainability of medical devices: what impact on clinical evaluation?, Circular economy of medical devices: reconciling clinical performance, sustainability and regulatory requirements
